Skip to main content

Quest Diagnostics Value Stock - Dividend - Research Selection

Quest diagnostics

ISIN: US74834L1008 , WKN: 904533

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. The company\'s Diagnostic Information Services business segment develops and delivers diagnostic testing information and services, such as routine testing, non-routine and advanced clinical testing, gene-based and esoteric testing, anatomic pathology, and other diagnostic information services. This segment offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. Its Diagnostic Solutions segment offers risk assessment services for the life insurance industry; and health information technology solutions for healthcare organizations and clinicians. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Quest Diagnostics (DGX) to Expand in Canada With LifeLabs Buyout

2024-07-04
By integrating LifeLabs into its operations, Quest Diagnostics (DGX) aims to enhance the accessibility and quality of diagnostic services for Canadians.

Quest Diagnostics to acquire Canada’s LifeLabs for $985m

2024-07-04
Upon completion of the deal, LifeLabs will retain its headquarters, brand, and management team.

Quest Diagnostics, Southwest Airlines rise; Simulations Plus falls, Wednesday, 7/3/2024

2024-07-03
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quest Diagnostics expands into Canada with nearly $1 billion LifeLabs deal

2024-07-03
LifeLabs, which provides community laboratory tests, would retain its brand, Canadian headquarters and management after the acquisition is closed. The U.S. laboratory operator will acquire 100% of the equity of LifeLabs and expects to fund the acquisition through cash on hand and debt.

Quest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for Canadians

2024-07-03
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a definitive agreement with OMERS to acquire LifeLabs, a trusted provider of community laboratory tests for millions of Canadians, for a value of approximately CAN $1.35 billion (approximately USD $985 million), including net debt.

OMERS selling LifeLabs to Quest Diagnostics in deal valued at $1.35B

2024-07-03
TORONTO — Ontario pension fund manager OMERS has signed a deal to sell medical lab company LifeLabs to U.S.-based firm Quest Diagnostics in a deal valued at $1.35 billion including debt.Quest...

Quest Diagnostics expands into Canada with nearly $1 bln LifeLabs deal

2024-07-03
Quest Diagnostics said onWednesday it would acquire Canada-based LifeLabs from pensionplan owner OMERS for about C$1.35 billion, or about $985million, including net debt. LifeLabs,...

Quest Diagnostics to acquire LifeLabs for $985 million

2024-07-03
Quest Diagnostics said onWednesday it would acquire LifeLabs, a provider of communitylaboratory tests, from OMERS for about C$1.35 billion, or about$985 million.(Reporting by Sneha S K in...

Dividend Champion, Contender, And Challenger Highlights: Week Of June 30

2024-06-29
Stay up to date on dividend activity with a weekly summary for Dividend Champions, Contenders, and Challengers, along with changes and key dates.

Deutsche Numis Gives a Hold Rating to Quest Diagnostics (DGX)

2024-06-28
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.